Skip to main content

ADVERTISEMENT

Olivier Costerousse, PhD

Original Contribution
08/01/2008
Drug-eluting stents (DES) have revolutionized modern interventional cardiology by providing distinct advantages over bare-metal stents (BMS) in reducing the risk of in-stent restenosis. Several randomized clinical trials have consistently...
Drug-eluting stents (DES) have revolutionized modern interventional cardiology by providing distinct advantages over bare-metal stents (BMS) in reducing the risk of in-stent restenosis. Several randomized clinical trials have consistently...
Drug-eluting stents (DES) have...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
08/01/2008
Drug-eluting stents (DES) have revolutionized modern interventional cardiology by providing distinct advantages over bare-metal stents (BMS) in reducing the risk of in-stent restenosis. Several randomized clinical trials have consistently...
Drug-eluting stents (DES) have revolutionized modern interventional cardiology by providing distinct advantages over bare-metal stents (BMS) in reducing the risk of in-stent restenosis. Several randomized clinical trials have consistently...
Drug-eluting stents (DES) have...
08/01/2008
Journal of Invasive Cardiology